VENTURA, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.214
EU - Europa 17.864
AS - Asia 10.402
SA - Sud America 1.503
AF - Africa 209
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 17
Totale 51.251
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.787
IT - Italia 5.786
GB - Regno Unito 4.826
SG - Singapore 3.017
SE - Svezia 2.827
CN - Cina 2.796
BR - Brasile 1.141
HK - Hong Kong 1.136
DE - Germania 1.076
VN - Vietnam 1.064
FI - Finlandia 636
FR - Francia 624
BD - Bangladesh 599
UA - Ucraina 568
TR - Turchia 401
RU - Federazione Russa 397
KR - Corea 353
NL - Olanda 303
IN - India 282
CA - Canada 241
BG - Bulgaria 178
ID - Indonesia 143
AR - Argentina 135
MX - Messico 105
PL - Polonia 100
IQ - Iraq 89
BE - Belgio 80
JP - Giappone 77
ZA - Sudafrica 75
IE - Irlanda 69
ES - Italia 66
MY - Malesia 57
AE - Emirati Arabi Uniti 53
EC - Ecuador 47
CO - Colombia 45
CH - Svizzera 43
LT - Lituania 40
RO - Romania 40
AT - Austria 36
CL - Cile 36
VE - Venezuela 36
AU - Australia 35
CZ - Repubblica Ceca 35
PH - Filippine 33
PK - Pakistan 32
UZ - Uzbekistan 30
SA - Arabia Saudita 24
IR - Iran 23
JO - Giordania 23
PE - Perù 23
MA - Marocco 22
PY - Paraguay 21
AZ - Azerbaigian 20
DZ - Algeria 19
EG - Egitto 19
GR - Grecia 19
IL - Israele 19
NP - Nepal 19
JM - Giamaica 18
PT - Portogallo 18
TH - Thailandia 16
NO - Norvegia 15
TN - Tunisia 15
CR - Costa Rica 14
KE - Kenya 14
TW - Taiwan 14
AL - Albania 12
EU - Europa 12
BO - Bolivia 11
BH - Bahrain 10
KG - Kirghizistan 9
RS - Serbia 9
SY - Repubblica araba siriana 9
TT - Trinidad e Tobago 9
DK - Danimarca 8
DO - Repubblica Dominicana 8
GT - Guatemala 8
BY - Bielorussia 7
CY - Cipro 7
ET - Etiopia 7
MD - Moldavia 7
OM - Oman 7
SK - Slovacchia (Repubblica Slovacca) 7
HU - Ungheria 6
MK - Macedonia 6
NG - Nigeria 6
NZ - Nuova Zelanda 6
UY - Uruguay 6
HN - Honduras 5
KZ - Kazakistan 5
NI - Nicaragua 5
PA - Panama 5
PS - Palestinian Territory 5
SN - Senegal 5
AM - Armenia 4
CI - Costa d'Avorio 4
HR - Croazia 4
LB - Libano 4
LK - Sri Lanka 4
AO - Angola 3
Totale 51.180
Salva come PNG Salva come JPEG
Città #
Southend 3.859
Ashburn 2.101
Santa Clara 1.969
Singapore 1.881
Stockholm 1.798
Fairfield 1.791
Chandler 1.194
Hong Kong 1.115
Woodbridge 1.107
Houston 1.089
San Jose 932
Hefei 930
Jacksonville 820
Ann Arbor 621
Seattle 605
Wilmington 596
Dearborn 574
Cambridge 568
Nyköping 555
London 549
Beijing 535
Helsinki 468
Rome 404
Milan 376
Ho Chi Minh City 367
Los Angeles 358
Chicago 346
Council Bluffs 339
Seoul 337
Dallas 301
Modena 248
The Dalles 246
New York 241
Hanoi 235
Berlin 212
Izmir 196
San Diego 186
Princeton 181
Sofia 169
Eugene 150
Munich 147
Lauterbourg 142
São Paulo 119
Buffalo 115
Moscow 115
Shanghai 109
Salt Lake City 108
Bologna 102
Naples 92
Bremen 89
Jakarta 89
Orem 85
Des Moines 75
Frankfurt am Main 75
Parma 75
Toronto 74
Columbus 71
Palermo 70
Phoenix 69
Brussels 68
Rimini 66
Florence 64
Warsaw 62
Montreal 59
Verona 57
Amsterdam 55
Tokyo 55
Turin 54
Redwood City 53
Chennai 51
Yalova 50
Dublin 49
Falls Church 49
Bari 48
Catania 47
Da Nang 46
Rio de Janeiro 44
Tampa 44
Haiphong 42
Johannesburg 41
Mexico City 40
Atlanta 37
Fremont 37
Brooklyn 36
Elk Grove Village 36
Guangzhou 36
Denver 35
Turku 35
Boston 34
Manchester 34
Boardman 33
Mumbai 33
Padova 32
Paris 32
Miano 31
Poplar 30
Brasília 29
Dhaka 29
Kunming 29
Belo Horizonte 27
Totale 34.139
Salva come PNG Salva come JPEG
Nome #
Effetti dell’insulina sui livelli di omocisteina plasmatica in pazienti con diabete mellito tipo ii con e senza intolleranza alla metionina 2.494
Alterations in iron status predict cardiac response to blood transfusion in -thalassemia major 1.832
Validating the Body Uneasiness Test (BUT) in obese patients 719
Terapia antialadosteronica e prevenzione della cardiomiopatia cirrotica 711
Weight Loss Expectations in Obese Patients and Treatment Attrition: An Observational Multicenter Study 702
Trombosi portale e iperomocisteinemia in pazienti con cirrosi epatica 665
Isomeri urinari della Coproporfirina in pazienti con Epatopatie Colestatiche Acquisite e sindrome di Dubin-Johnson 590
Impiego dei marcatori di neoplasia (CEA, CA 19.9, CA 125, CA 16.3, NSE) in Medinina Interna: uno studio retrospettivo 573
Oxford Manuale di Medicina Clinica 556
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis 504
The QUOVADIS Study: features of obese Italian patients seeking treatment at specialist centers 503
04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report 485
Hyperhomocysteinaemia in chronic liver diseases: role of disease stage, vitamin status and methylenetetrahydrofolate reductase genetics 482
04092 Liver function, iron status, and hemopoiesis in erythropoietic protoporphyria (EPP): insights into a complex interplay 478
A challenging diagnosis for potential fatal diseases: Recommendations for diagnosing acute porphyrias 433
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 423
Acute Intermittent Porphyria in a Child with Severe Neuropathy 409
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy 403
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study) 402
Safety and efficacy of sucrosomal iron in inflammatory bowel disease patients with iron deficiency anemia 394
EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks 379
The Acute Porphyric Attack: A Difficult Diagnosis for a Potential Lethal Event in Emergency Medicine 378
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 374
Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report 366
A role for homocysteine increase in haemolysis of megaloblastic anaemias due to vitamin B-12 and folate deficiency: results from an in vitro experience 358
Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis. 356
Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. 350
Serum and Liver Iron Differently Regulate the Bone Morphogenetic Protein 6 (BMP6)-SMAD Signaling Pathway in Mice 350
HYPERHOMOCYSTEINEMIA AND MTHFR C677T POLYMORPHISM IN PATIENTS WITH PORTAL VEIN THROMBOSIS COMPLICATING LIVER CIRRHOSIS 337
Antiviral treatment profoundly affects iron status in HCV patients: Implications for management and treatment outcome 334
MARKERS OF ENDOTHELIAL DYSFUNCTION AS PREDICTORS OF ASCITIC DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS. 334
IS FLOW-MEDIATED DILATATION (FMD) ASSESSMENT A RELIABLE MARKER OF ENDOTHELIAL DYSFUNCTION IN LIVER CIRRHOSIS? 334
Weight Loss Expectations in Obese Patients Seeking Treatment at Medical Centers 330
Hepatocellular Carcinoma in HIV-infected Patients: Check Ealy, Treat Hard 325
Alendronate treatment for osteoporosis in patients infected with human immunodeficiency virus. 323
N-acetyl-cysteine reduces homocysteine plasma levels after single intravenous administration by increasing thiols urinary excretion 319
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 319
ANTIALDOSTERONE THERAPY IN LIVER CIRRHOSIS: A ROLE FOR PREVENTION OF CIRROTHIC CARDIOMIOPATHY? 315
Psychological Distress in Morbid Obesity in Relation to Weight History 313
Drugs and acute porphyrias: reasons for a hazardous relationship 313
Antialdosterone therapy in liver cirrhosis: a role for prevention of cirrhitc cardiomiopathy ? 312
The Metabolic Syndrome in Treatment-Seeking Obese Persons 308
Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease. 307
Tumour markers in internal medicine: a low-cost test or an unnecessary expense? A retrospective study based on appropriateness 306
A large deletion on chromosome 11 in acute intermittent porphyria 305
MTHFR C677T polymorhism and hyperhomocysteinemia in patients with liver cirrhosis complicated by portal vein thrombosis and hepatocellular carcinoma 302
Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians 302
HIV INFECTION AND SURVIVAL IN PATIENTS WITH HCCAND LIVER CIRRHOSIS 301
Molecular characterization, by digital PCR analysis of four HMBS gene mutations affecting the ubiquitous isoform of Porphobilinogen Deaminase (PBGD) in patients with Acute Intermittent Porphyria (AIP) 301
EXPLORE: A prospective, multinational natural history study of acute hepatic porphyria patients with recurrent attacks 296
Anti- and pro-oxidant factors and endothelial dysfunction in chronic cigarette smokers with coronary heart disease 294
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 294
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad? 294
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 292
Clinical, biochemical and genetic characteristics of Variegate Porphyria in Italy 291
Radiofrequency ablation combined with transcatheter arterial chemioembolization in the treatment of advanced hepatocellular carcinoma 289
Weight cycling in treatment-seeking obese persons: data from the QUOVADIS study 287
Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives 286
Pro-oxidant and antioxidant factors in acute intermittent porphyria: Family studies 285
Continuous combined hormone replacement therapy with oral 17β-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women 282
Urinary coproporhyrin isomers during therapy with IFn-RIBA in patients with chronic hepatitis due to HCV infection 281
Red wine consumption prevents vascular oxidative stress induced by a high-fat meal in healthy volunteers 281
Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy 278
Affinità dell'omocisteina per le lipoproteine 278
Role of Multidrug-Resistance Protein 2 in coproporphyrin transport: results from experimental studies in bile fistula rat models 276
Flow-mediated dilatation (FMD) assessment as a marker of endothelial dysfunction in liver cirrhosis 275
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C 275
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 268
Prevention of a first episode of variceal bleeding: role of duplex Doppler sonographic measurement of the acute response to beta-blockers. 267
THE MOLECULAR BASIS FOR THE HEPATIC REGULATION OF HEPCIDIN, THE IRON HORMONE, BY BONE MORPHOGENETIC PROTEINS. 264
Parametri predittivi e risposta sostenuta alla terapia antivirale combinata nell'epatite cronica attivva HCV correlata (ECA HCV) 258
The Effect of Obesity Management on Body Image in Patients Seeking Treatment at Medical Centers 257
Portal vein thrombosis and thrombophilia in liver cirrhosis: a role for hyperhomocysteinemia ? 257
Relevance of different apolipoprotein content in binding of homocysteine to plasma lipoproteins 254
Snoring, hypertension and Type 2 diabetes in obesity. Protection by physical activity 254
Correlation between plasma malonyldialdeide levels and paroxonase activity in healthy subjects and in patients with atherosclerotic disease 252
Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats 251
A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review 251
THE INTERACTION OF BILIAR ACIDS WITH 2-HYDROXYPROPYL-CYCLODEXTRIN IN SOLUTION AND IN THE SOLID STATE 250
Serum endothelin-1 as predictor of ascitic decompensation in patients with liver cirrhosis 250
Rilevanza del diverso contenuto apolipoproteico nel legame dell’omocisteina alle lipoproteine 248
Guidelines for the management of acute porphyria: recommendations from the International Porphyria Network 246
Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects 246
Does the measurement of portal flow velocity have any value in the identification of patients with cirrhosis at risk of digestive bleeding ? 245
Alendronate for the treatment of Osteoporosis in HIV-infected patients. 244
Ataxia-myoclonus syndrome in patients with SARS-CoV2 infection 244
Peroxidation indices and total antioxidant capacity in plasma during hyperhomocysteinemia induced by methionine oral loading 243
Recovery of chronic motor neuropathy due to acute intermittent porphyria after givosiran treatment in a young boy: a case report 242
Improvement of survival in patients with intermediate stage (BCLC-B) hepatocellular acrcinoma complicating liver cirrhosis by combination therapy with radiofrequency ablation and transcatheter chemioembolization 242
Sarcoma primitivo del cuore. Descrizione di un caso 241
Plasma nitric oxide production during acute hyperhomocysteinemia in atherosclerotic patients and controls 239
Distribution of homocysteine in plasma lipoproteins 239
Iron Metabolism in the Disorders of Heme Biosynthesis 238
Markers of Endothelial Dysfunction in patients with liver cirrhosis with anh without portal hypertension 238
Acute Hepatic Porphyrias: “Purple Flags”—Clinical Features that should Prompt Specific Diagnostic Testing 237
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria 236
Impact of nutrition on cognition and affectivity in the elderly: A review 235
Construct Validity of the Short Form-36 Health Survey and Its Relationship with BMI in Obese Outpatients 234
Novel human pathological mutations. Gene symbol: PPOX. Disease: porphyria, variegate 234
Urinary and plasma homocysteine and cysteine levels during prolonged oral N-acetylcysteine therapy 233
Totale 36.580
Salva come PNG Salva come JPEG
Categoria #
all - tutte 168.241
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 168.241
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021299 0 0 0 0 0 0 0 0 0 0 0 299
2021/20223.669 178 412 290 308 143 217 211 219 407 316 538 430
2022/20234.119 423 420 318 370 452 551 118 389 491 112 229 246
2023/20242.739 168 179 241 227 399 196 225 336 115 124 192 337
2024/20258.142 322 149 325 583 1.543 1.083 598 494 885 337 858 965
2025/202617.679 1.010 748 1.368 1.491 1.785 1.117 1.782 828 3.445 1.625 1.487 993
Totale 51.530